Journey Medical Corporation Annual report [Section 13 and 15(d), not S-K Item 405]

REVENUES FROM CONTRACTS WITH CUSTOMERS - Significant customers (Details)

REVENUES FROM CONTRACTS WITH CUSTOMERS - Significant customers (Details) - Customer concentration risk - customer	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Product revenue \| Customer
REVENUES FROM CONTRACTS WITH CUSTOMERS
Number of customers	0	0
Accounts receivable \| Customer
REVENUES FROM CONTRACTS WITH CUSTOMERS
Number of customers	0
Accounts receivable \| One customer
REVENUES FROM CONTRACTS WITH CUSTOMERS
Number of customers		1
Concentration risk, percentage		10.30%

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References + Details